Assignee
BICYCLERD LTD
GB·23 granted patents·17 pending applications·314 citations·filing 2012–2025
Top patents by PatentIndex Score
40 records- 0196US11746126B2Bicyclic peptide ligands with detectable moieties and uses thereofBICYCLERD LTD·Filed 2020·Granted Sep 5, 2023·15 cites·22 claims
- 0296US11672868B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2021·Granted Jun 13, 2023·16 cites·19 claims
- 0396US11103591B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Aug 31, 2021·20 cites·24 claims
- 0496US10792368B1Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2020·Granted Oct 6, 2020·23 cites·14 claims
- 0596US9932367B2Modification of polypeptidesBICYCLERD LTD·Filed 2015·Granted Apr 3, 2018·25 cites·13 claims
- 0695US11433137B2Compounds for treating cancerBICYCLERD LTD·Filed 2019·Granted Sep 6, 2022·15 cites·28 claims
- 0795US10994019B2Bicyclic peptide-toxin conjugates specific for MT1-MMPBICYCLERD LTD·Filed 2017·Granted May 4, 2021·20 cites·17 claims
- 0895US10899798B2Bicyclic peptide ligands with detectable moieties and uses thereofBICYCLERD LTD·Filed 2018·Granted Jan 26, 2021·20 cites·17 claims
- 0995US10894808B2Polypeptide ligands specific for plasma kallikreinBICYCLERD LTD·Filed 2019·Granted Jan 19, 2021·17 cites·42 claims
- 1094US11814447B2Peptide ligands for binding to EphA2BICYCLERD LTD·Filed 2019·Granted Nov 14, 2023·14 cites·19 claims
- 1194US11623012B2Bicyclic peptide ligands specific for EphA2BICYCLERD LTD·Filed 2018·Granted Apr 11, 2023·15 cites·9 claims
- 1294US10800813B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2012·Granted Oct 13, 2020·24 cites·48 claims
- 1394US10532106B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2015·Granted Jan 14, 2020·32 cites·12 claims
- 1493US12318454B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2023·Granted Jun 3, 2025·1 cites·13 claims
- 1593US11946041B2Modification of polypeptidesBICYCLERD LTD·Filed 2018·Granted Apr 2, 2024·14 cites·17 claims
- 1693US11414488B2Methods for treating cancerBICYCLERD LTD·Filed 2020·Granted Aug 16, 2022·16 cites·21 claims
- 1793US10294274B2Polypeptide ligands specific for plasma kallikreinBICYCLERD LTD·Filed 2014·Granted May 21, 2019·27 cites·2 claims
- 1882US2025255975A1Bicyclic peptide ligands specific for mt1-mmpBICYCLERD LTD·Filed 2025·Application pending·0 cites
- 1977US12552837B2Bicyclic peptide ligands with detectable moieties and uses thereofBICYCLERD LTD·Filed 2023·Granted Feb 17, 2026·0 cites·3 claims
- 2074US2024199742A1Methods for treating cancerBICYCLERD LTD·Filed 2023·Application pending·0 cites
- 2170US2024181069A1Methods for treating cancerBICYCLERD LTD·Filed 2023·Application pending·0 cites
- 2269US2023025971A1Methods for treating cancerBICYCLERD LTD·Filed 2022·Application pending·0 cites
- 2368US11912794B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2020·Granted Feb 27, 2024·0 cites·19 claims
- 2468US11753444B2Modulation of structured polypeptide specificityBICYCLERD LTD·Filed 2020·Granted Sep 12, 2023·0 cites·21 claims
- 2564US2023165966A1Methods for treating cancerBICYCLERD LTD·Filed 2022·Application pending·0 cites
- 2662US2024408219A1Bicyclic peptide ligand drug conjugatesBICYCLERD LTD·Filed 2022·Application pending·0 cites
- 2759US12377155B2Bicyclic peptide ligands specific for PSMABICYCLERD LTD·Filed 2019·Granted Aug 5, 2025·0 cites·14 claims
- 2856US2024018508A1Phage cyclisation assayBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 2952US12551567B2Bicyclic peptide ligands specific for PD-L1BICYCLERD LTD·Filed 2019·Granted Feb 17, 2026·0 cites·19 claims
- 3052US12491253B2Bicyclic peptide ligands specific for MT1-MMPBICYCLERD LTD·Filed 2019·Granted Dec 9, 2025·0 cites·15 claims
- 3151US2022008545A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR FAPaBICYCLERD LTD·Filed 2019·Application pending·0 cites
- 3250US2022135614A1Synthesis of bicycle toxin conjugates, and intermediates thereofBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 3349US2022133733A1Bicyclic peptide ligands specific for cd38BICYCLERD LTD·Filed 2020·Application pending·0 cites
- 3449US2020291096A1Bicyclic peptide ligand sting conjugates and uses thereofBICYCLERD LTD·Filed 2018·Application pending·0 cites
- 3549US2022133732A1Bicyclic peptide ligands specific for caixBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 3649US2022119488A1Bicyclic peptide ligands specific for integrin alpha-v-beta-3BICYCLERD LTD·Filed 2020·Application pending·0 cites
- 3747US2020129630A1Methods for treating cancerBICYCLERD LTD·Filed 2019·Application pending·0 cites
- 3846US2022024983A1Bicyclic peptide ligands specific for il-17BICYCLERD LTD·Filed 2019·Application pending·0 cites
- 3944US2022387611A1Methods for treating cancerBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 4043US2020283482A1Bicyclic peptide ligand prr-a conjugates and uses thereofBICYCLERD LTD·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →